Utilization of Nanoparticles, Nanodevices, and Nanotechnology in the Treatment Course of Cutaneous Melanoma (Adv. Therap. 7/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202100208
- By:
- Publication type:
- Article
Works matching IS 23663987 AND DT 2022 AND VI 5 AND IP 7
Results: 11
1
2
Masthead (Adv. Therap. 7/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202270015
- Publication type:
- Article
3
Engineered Circular RNA CircmiR‐29b Attenuates Muscle Atrophy by Sponging MiR‐29b (Adv. Therap. 7/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202270014
- By:
- Publication type:
- Article
4
Co‐Anchoring of Engineered Immunogen and Immunostimulatory Cytokines to Alum Promotes Enhanced‐Humoral Immunity (Adv. Therap. 7/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202270013
- By:
- Publication type:
- Article
5
Novel Therapeutic Strategy for Bacteria‐Contaminated Bone Defects: Reconstruction with Multi‐Biofunctional GO/Cu‐Incorporated 3D Scaffolds.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202200043
- By:
- Publication type:
- Article
6
Identification of Candidate Antigens and Immune Subtypes in Colon Cancer for mRNA Vaccine Development.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202200036
- By:
- Publication type:
- Article
7
An Adaptable Antibody‐Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202200008
- By:
- Publication type:
- Article
8
Co‐Anchoring of Engineered Immunogen and Immunostimulatory Cytokines to Alum Promotes Enhanced‐Humoral Immunity.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202100235
- By:
- Publication type:
- Article
9
Micro/Nanorobots as Active Delivery Systems for Biomedicine: From Self‐Propulsion to Controllable Navigation.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202100228
- By:
- Publication type:
- Article
10
Utilization of Nanoparticles, Nanodevices, and Nanotechnology in the Treatment Course of Cutaneous Melanoma.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202100208
- By:
- Publication type:
- Article
11
Engineered Circular RNA CircmiR‐29b Attenuates Muscle Atrophy by Sponging MiR‐29b.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202200029
- By:
- Publication type:
- Article